A new type of whole-body magnetic resonance imaging (MRI) test could be an alternative to standard positron emission tomography/computed tomography (PET/CT) imaging for assessing cancer in children and young adults, but without exposure to ...
Tags: MRI, radiation, tumour visibility
Omeros Corporation (NASDAQ: OMER) today announced positive results from a Phase 2a clinical trial of OMS824, the company's phosphodiesterase 10 (PDE10) inhibitor, in which the drug was well tolerated and demonstrated comparable systemic ...
Royal Philips has introduced its Vereos PET/CT fully digital positron emission tomography/computed tomography (PET/CT) imaging system and its IQon Spectral CT spectral detector-based computed tomography (CT) imaging system at the 99th ...
Tags: CT System, spectral detector
Cognoptix disclosed at the ‘Clinical Trials on Alzheimer’s Disease’ (CTAD) scientific meeting the strong results of a multi-site clinical trial of its SAPPHIRE II eye test, which is designed to identify Alzheimer’s ...
Tags: Cognoptix Eye, Alzheimer's Disease
Photonics, a developer of leading-edge photonics technologies for medical, industrial and scientific markets, has received an order for its Lutetium Fine Silicate (LFS) scintillation crystals from its Japanese partner Hamamatsu Photonics. ...
Tags: Photonics, Scintillation Crystals, Pet Scanning Device
Eli Lilly and Company has acquired two investigational positron emission tomography (PET) tracers from Siemens Medical Solutions USA. PET tracers are aimed to image tau (or neurofibrillary) tangles in the brain, one of two known hallmarks ...
Tags: Eli Lilly, Alzheimer's Research
Threshold Pharmaceuticals has signed a global agreement with Siemens Healthcare to purchase its investigational radiolabeled hypoxia positron emission tomography (PET) tracer, [18F]HX4 [flortanidazole (18F)]. The US-based biotechnology ...
Eli Lilly and Company and Avid Radiopharmaceuticals have announced the approval of Amyvid (Florbetapir (18F)) solution for injection in European Union to detect the beta-amyloid neuritic plaque density in patients with cognitive impairment ...
Tags: diagnostic radiopharmaceutical, Eli Lilly Amyvid, disease
NorthShore University HealthSystem has used Amyvid (Florbetapir F 18 Injection) radioactive diagnostic agent to evaluate patients for Alzheimer's disease. The diagnostic agent, approved for positron emission tomography (PET) imaging ...
Tags: clinical trial, Alzheimer's disease, positron emission tomography
Neusoft Positron Medical Systems, a joint venture between China's Neusoft and America's Positron has obtained two key certifications for its Attrius Positron Emission Tomography (PET) systems. The new certifications comprise CE mark ...
Tags: Neusoft Positron, PET, key certifications
IBA Molecular has entered into an agreement to manufacture and distribute Piramal's new diagnostic imaging agent, 18F-Florbetaben, in the US and Europe. 18F-Florbetaben, which is currently in development for use with positron emission ...
Tags: 18F-Florbetaben, clincical product, clinical technology
Eli Lilly and Company and Avid Radiopharmaceuticals have gained positive CHMP opinion for Amyvid (Florbetapir F 18 injection) for the use as a diagnostic tool for positron emission tomography (PET) imaging of beta-amyloid plaque density in ...
Tags: Amyvid, Positive CHMP Opinion, Cognitive Impairment Diagnosis